Search for Novartis AG and
    1. March 30, 2015

      UnitedHealth pays $13bn for drug-benefits manager amid deal flurry

      The largest US health insurer is to spend almost $13bn to buy a company that manages prescription medicines for 35m...

    2. March 29, 2015

      Medics welcome GSK deal to provide meningitis B vaccine

      Patient groups and medics have welcomed an agreement between the government and GlaxoSmithKline to make Britain the first...

    Special Reports

    1. Special Report: Boldness in Business 2012

      Seven success stories are honoured in this year’s awards...
    2. Combating Cancer

      A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
    Search more Special Reports on this topic.

    1. March 22, 2015

      Apple and Google stake a claim on big pharma’s turf

      Within 24 hours of Apple launching its platform for health research this month, tens of thousands of iPhone users had signed...

    2. March 15, 2015

      Pharma sector hails ‘sea change’ in heart disease treatment

      The pharmaceuticals industry has hailed an impending “sea change” in the treatment of heart disease as it gears up to launch...

    3. March 12, 2015

      GSK to sell Aspen stake for £574m

      GlaxoSmithKline is to halve its stake in South Africa’s Aspen Pharmacare in a move expected to raise £574m. The deal marks...

    4. March 8, 2015

      Novartis leads way for big pharma cost-cuts

      Novartis is showing the way for big pharmaceutical groups to become more productive, according to its chief executive, as...

    5. March 6, 2015

      US regulators approve first biosimilar drug

      US regulators have approved the first of a new class of drugs called biosimilars, which promise to shave billions of dollars...

    6. March 2, 2015

      GSK-Novartis deal ‘a model’ for industry

      A $2bn disposal by Johnson & Johnson and the completion of a $20bn asset swap between GlaxoSmithKline and Novartis on Monday...

    7. March 1, 2015

      Chi-Med poised for China drug milestone

      A UK-listed company backed by Li Ka-shing, one of Asia’s richest men, says it is moving closer to producing the first modern...

    8. February 25, 2015

      Pharmacyclics considers $19bn sale

      Pharmacyclics is considering a sale that could value the US cancer drugs maker at about $19bn, according to people familiar...

    9. February 6, 2015

      Pharma takes a dose of sense from the deals doctor

      Taking the wrong combination of drugs can have serious side effects. The same goes for pharmaceuticals dealmaking. Mix up...

    10. February 4, 2015

      Ackman’s Pershing Square secures seat on Zoetis board

      Bill Ackman, the billionaire hedge fund activist, has parachuted one of his representatives on to the board of Zoetis, the...

    11. February 3, 2015

      Novartis faces suspension in Japan over drug trial allegations

      Novartis faces a temporary suspension of its business in Japan as punishment for alleged manipulation of clinical trial data...

    12. February 2, 2015

      Big pharmaceuticals groups faces biosimilars challenge

      Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

    13. January 29, 2015

      Roche and Qualcomm in digital health alliance

      Roche has forged an alliance with Qualcomm to develop remote patient-monitoring systems in the latest sign of digital...

    14. January 27, 2015

      Novartis vows cost cuts after Swiss franc surge

      Novartis has leapt to the defence of the Swiss National Bank for removing the cap on the Swiss franc against the euro and...

    15. January 16, 2015

      Swiss surge could boost income investors

      UK investors who hold European and even UK equity income funds stand to benefit from the Swiss National Bank’s decision to...

    16. January 15, 2015

      Swiss franc: Bern marks

      It is a rare tsunami that hits a landlocked nation in the mountains of Europe. So the metaphor is an odd choice to describe...

    17. January 9, 2015

      Small-cap Week, January 10

      Inhaler developer Vectura was among the biggest small-cap gainers this week, amid growing optimism over its royalty revenue....

    18. January 6, 2015

      FDA paves way for biosimilar drug approval

      The US pharmaceuticals watchdog has published a bullish assessment of a copycat biotech drug, paving the way for it to...

    19. December 28, 2014

      Malaria: Real and present danger

      Ka Lar Nar’s fellow east Myanmar villagers chuckle at the story of his periodic headaches because they know he likes his...

    20. December 17, 2014

      Juno Therapeutics vies for cancer treatment lead

      When Juno Therapeutics lists on Nasdaq on Friday, it will be one of the biggest events in a big year for the buoyant US...

    21. December 10, 2014

      Emphasis shifts from illness care to well care

      Spire, a small stone-like device less than the size of a walnut, clips on to your belt or bra quietly collecting information...

    22. December 10, 2014

      India assumes frontline position in battles over intellectual property rights

      As their cities grow more polluted, more people in India grapple with respiratory difficulties. The Swiss multinational...

    23. November 17, 2014

      GlaxoSmithKline leads Access to Medicine Index

      GlaxoSmithKline is leading the pharmaceuticals industry in efforts to widen global access to medicines, according to a...

    24. November 7, 2014

      UCB caps week of pharma dealmaking

      UCB of Belgium wrapped up another busy week of pharmaceuticals dealmaking on Friday with the $1.5bn disposal of its US...

    25. FT Alphaville

      October 29, 2014

      This is BABA, what's your target price? [updated]

      First on Alibaba, the FT reports that the Cayman registered derivative contract vaguely related to ecommerce in China — and...

    26. October 28, 2014

      Alibaba’s market value nudges Walmart

      Alibaba, the Chinese ecommerce behemoth that listed in New York last month, briefly muscled ahead of Walmart by one...

    27. October 22, 2014

      Witty riposte will only go some way to pacify drug group’s doubters

      Dull quarterly earnings statements with incremental numbers? Not for Sir Andrew Witty, chief executive of drugs giant...

    28. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    29. October 10, 2014

      Novartis strikes deal with Oxford BioMedica for cancer treatment

      Novartis will take a stake in Oxford BioMedica as part of a deal that will see the Swiss drugmaker work with the UK gene...

    30. September 26, 2014

      Drug development: Big pharma back in the game it made

      Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

    31. July 29, 2014

      Time for business to experiment with wearables

      From digital wrist bands and smart watches to intelligent skin patches and head-mounted displays, this is the year of...

    32. July 28, 2014

      GSK and Reckitt: pharming out

      Well done Reckitt Benckiser and GlaxoSmithKline. But what took you so long? Both have recognised that pharmaceuticals and...

    33. July 23, 2014

      Longtime GSK favourite stumbles in the final furlong

      The Queen’s horse Estimate, former Gold Cup champion, has failed a drug test, as has GlaxoSmithKline. On Wednesday the group...

    34. July 18, 2014

      Technology: Wear your medicine

      Walter de Brouwer’s life changed when his son fell 35 feet from a window. Spending anxious months in intensive care, the...

    35. July 17, 2014

      Novartis maintains forecasts despite weak quarter

      Novartis confirmed its full-year profit and revenue forecasts, despite weaker than expected second-quarter results and the...

    36. July 15, 2014

      Big pharma teams up with big data

      Big pharma and Silicon Valley have been circling one another for some time, looking for ways in which they might harness the...

    37. July 15, 2014

      Google and Novartis to develop ‘smart’ contact lens for diabetics

      Google has struck a deal with Novartis to jointly develop “smart” contact lenses in the first alliance of its kind between...

    38. July 8, 2014

      AbbVie / Shire: debt and diversification

      The market does not think it will happen. AbbVie has upped its bid for Shire from £46.26 to £51.15 per share. In response,...

    Search for Novartis AG and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Lex on potential conflict at Swiss drugs group...
      July 17, 2013

      Lex on potential conflict at Swiss drugs group

    2. Lex on Novartis' payment to its outgoing chairman...
      February 18, 2013

      Lex on Novartis' payment to its outgoing chairman